Form 4: Dexcom Director Nicholas Augustinos Transfers Shares to Revocable Trust
SEC Form 4 Filing
Director Nicholas Augustinos transferred shares of Dexcom Inc. common stock to the Kirschner/Augustinos Revocable Trust.
Summary
- On May 18, 2024, Nicholas Augustinos, a director of Dexcom Inc., transferred 3,043 shares of Dexcom common stock from direct ownership to the Kirschner/Augustinos Revocable Trust.
- The transfer occurred upon the vesting of previously awarded restricted stock units.
- Following the transaction, Augustinos directly owns 0 shares and indirectly owns 37,083 shares through the trust.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transfer of shares for estate planning purposes. It doesn't convey any particularly positive or negative sentiment regarding the company's performance or outlook.
Industry Context
This is a routine disclosure related to insider transactions and doesn't necessarily reflect a change in the company's outlook or performance.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on Dexcom's stakeholders, as it represents a personal financial planning decision by a director.
Key Dates
| Date | Description |
|---|---|
| 05/18/2024 | Date of share transfer to the Kirschner/Augustinos Revocable Trust |
| 05/21/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.